The Army of Women® connects you to researchers committed to solving important breast cancer questions.
Since its inception, the goal of the Army of Women has been to help researchers transition from experiments on mice and rats to women and men of every ethnicity, with and without breast cancer, across the world.
Our program builds and nurtures the critical relationship between researchers and our members. To ensure that we work with the highest-caliber researchers and studies, we have a multi-step review process required for all potential studies. All supported studies listed on our site have passed a review by each researcher’s Institutional Review Board (IRB), our Army of Women team, and scientists and breast cancer advocates on our Scientific Advisory Committee.
We will send periodic emails with information about supported breast cancer research studies that are recruiting volunteers. If you are interested in participating in a study, you simply click the ‘RSVP For This Study’ button and answer a few questions. If you are eligible, you will receive instructions on the next steps, including enrollment and participation details.
We provide a detailed description of the research background, study procedures, and eligibility criteria. If you fit the criteria and you’d like to participate, all you need to do is RSVP on the Army of Women website to let us know you are interested. Once we confirm that you are a good fit, the researcher will contact you for a secondary screening and answer any questions you might have about study participation.
We want to forge a partnership between our members and the scientific community. To facilitate this connection, we offer webinars to allow researchers recruiting via the Army of Women to speak with our members, discuss results, answer questions, and offer potential opportunities for further investigation based on their results.
Over the years the Army of Women has supported over 100 projects. Studies range from those investigating the causes of breast cancer and how to prevent it, to quality of life issues experienced during and after treatment, to drugs for prevention or treatment of metastatic breast cancer.